Literature DB >> 10223208

Differential expression of prostaglandin endoperoxide H synthase-2 and formation of activated beta-catenin-LEF-1 transcription complex in mouse colonic epithelial cells contrasting in Apc.

J M Mei1, N G Hord, D F Winterstein, S P Donald, J M Phang.   

Abstract

Mutations in Apc underlie the intestinal lesions in familial adenomatous polyposis and are found in >85% of sporadic colon cancers. They are frequently associated with overexpression of prostaglandin endoperoxide H synthase-2 (PGHS-2) in colonic adenomas. It has been suggested that Apc mutations are linked mechanistically to increased PGHS-2 expression by elevated nuclear accumulation of beta-catenin-Tcf-LEF transcription complex. In the present study, we show that PGHS-2 is differentially expressed in mouse colonic epithelial cells with distinct Apc status. Cells with a mutated Apc expressed markedly higher levels of PGHS-2 mRNA and protein and produced significantly more prostaglandin E2 than cells with normal Apc. Using electrophoretic mobility shift assays, we demonstrate that DNA-beta-catenin-LEF-1 complex formation is differentially induced in these two cell lines in an Apc-dependent manner. Our data indicate that the differential induction of beta-catenin-LEF-1 complex correlates closely with differential expression of PGHS-2. These findings support the hypothesis that the differential expression of PGHS-2 is mediated through the proposed beta-catenin/Tcf-LEF signaling pathway.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10223208     DOI: 10.1093/carcin/20.4.737

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  10 in total

Review 1.  Stem cell in gastrointestinal structure and neoplastic development.

Authors:  M Brittan; N A Wright
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

Review 2.  Gastric carcinogenesis and the cancer stem cell hypothesis.

Authors:  Yoshiro Saikawa; Kazumasa Fukuda; Tsunehiro Takahashi; Rieko Nakamura; Hiroya Takeuchi; Yuko Kitagawa
Journal:  Gastric Cancer       Date:  2010-04-07       Impact factor: 7.370

Review 3.  Mechanistic aspects of COX-2 expression in colorectal neoplasia.

Authors:  Dan A Dixon; Fernando F Blanco; Annalisa Bruno; Paola Patrignani
Journal:  Recent Results Cancer Res       Date:  2013

Review 4.  Beta-catenin--a linchpin in colorectal carcinogenesis?

Authors:  Newton Alexander Chiang Shuek Wong; Massimo Pignatelli
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

5.  Germinated brown rice (GBR) reduces the incidence of aberrant crypt foci with the involvement of beta-catenin and COX-2 in azoxymethane-induced colon cancer in rats.

Authors:  Saiful Yazan Latifah; Nurdin Armania; Tan Hern Tze; Yaacob Azhar; Abdul Hadi Nordiana; Saad Norazalina; Ithnin Hairuszah; Moin Saidi; Ismail Maznah
Journal:  Nutr J       Date:  2010-03-26       Impact factor: 3.271

Review 6.  The gastrointestinal stem cell.

Authors:  M Brittan; N A Wright
Journal:  Cell Prolif       Date:  2004-02       Impact factor: 6.831

7.  Protein Never in Mitosis Gene A Interacting-1 regulates calpain activity and the degradation of cyclooxygenase-2 in endothelial cells.

Authors:  Tongzheng Liu; Ryan A Schneider; Vaibhav Shah; Yongcheng Huang; Rostislav I Likhotvorik; Lakhu Keshvara; Dale G Hoyt
Journal:  J Inflamm (Lond)       Date:  2009-06-22       Impact factor: 4.981

8.  Characterisation of integrin-linked kinase signalling in sporadic human colon cancer.

Authors:  A Marotta; K Parhar; D Owen; S Dedhar; B Salh
Journal:  Br J Cancer       Date:  2003-06-02       Impact factor: 7.640

9.  Transition of treatment for patients with extra-abdominal desmoid tumors: nagoya university modality.

Authors:  Yoshihiro Nishida; Satoshi Tsukushi; Yoji Shido; Hiroshi Urakawa; Eisuke Arai; Naoki Ishiguro
Journal:  Cancers (Basel)       Date:  2012-02-07       Impact factor: 6.639

Review 10.  Potential targets for colorectal cancer prevention.

Authors:  Sally Temraz; Deborah Mukherji; Ali Shamseddine
Journal:  Int J Mol Sci       Date:  2013-08-22       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.